US FDA’s Woodcock Sees Clinical Trial Reform Coming, But ‘Not Wholly Optimistic’

Margaret Hamburg (left) and Janet Woodcock (right)
Former Commissioner Margaret Hamburg and Acting Commissioner Janet Woodcock reminisce about the duties of the job during the Milken Institute Partnering for Patients Forum. • Source: Screenshot from Milken Institute Partnering for Patients Forum
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D